Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas

被引:28
作者
Hemmerlein, B [1 ]
Markus, A [1 ]
Wehner, M [1 ]
Kugler, A [1 ]
Zschunke, F [1 ]
Radzun, HJ [1 ]
机构
[1] Univ Gottingen, Dept Pathol, D-37075 Gottingen, Germany
关键词
tumor-associated macrophages; renal cell cancer; macrophage differentiation;
D O I
10.1007/s002620000139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Tumor cells influence the differentiation of infiltrating macrophages. In the present study, the differentiation of macrophages in renal cell carcinomas was investigated with special regard to their possible role ill tumor growth and spread. Methods: Macrophages were characterized by means of immunohistochemistry of the Ki-M1P, 25F9, MRP8, MRP14, and MRP8/14 antigens and by means of in situ hybridization of CSF-1, its c-fins-coded corresponding receptor, and human monocytic serine esterase-1 (HMSE-1) mRNA. Macrophage subgroups were quantified within central tumor tissue, the corresponding turner host interface, and tumor-free tissue and correlated with tumor necrosis, fibrosis, and tumor stage and grade. Results: Macrophage density was much higher within tumor tissue and the tumor/host interface than in tumor-free tissue. Well-differentiated carcinomas showed a lower degree of macrophage density than less-differentiated carcinomas. Tumor-associated macrophages could be divided into an active inflammatory typo (MR14(+), MRP8/14(+)) and into a late-phase inflammatory type (25F9(+), MRP8(+)). Necrosis was seen in less-differentiated carcinomas and associated with a significantly increased density of MRP14(+) macrophages, which, however, did not correlate with the extent of necrosis. The density of 25F9(+) macrophages was correlated with an extensive connective tissue formation and an advanced tumor stage. c-fms, CSF-I, and HMSE-1 mRNA expression did not discriminate between the macrophage subgroups. Conclusions: Tumor-associated macrophages of the late-stage inflammatory type potentially support the spread of renal cell cancer. CSF-1 derived from tumor cells and macrophages acts as a monocyte attractant and induces macrophage differentiation able to modulate the extracellular matrix rather than to exert cytotoxicity. CSF-1 derived from tumor cells and macrophages acts as a monocyte attractant and induces macrophage differentiation able to modulate the extracellular matrix rather than to exert cytotoxicity.
引用
收藏
页码:485 / 492
页数:8
相关论文
共 36 条
[1]   Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives [J].
Andreesen, R ;
Hennemann, B ;
Krause, SW .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (04) :419-426
[2]   Identification of macrophage populations expressing tumor necrosis factor-α mRNA in acute multiple sclerosis [J].
Bitsch, A ;
da Costa, C ;
Bunkowski, S ;
Weber, F ;
Rieckmann, P ;
Brück, W .
ACTA NEUROPATHOLOGICA, 1998, 95 (04) :373-377
[3]  
BROCKER EB, 1987, CANCER IMMUNOL IMMUN, V25, P81
[4]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[5]  
DELABIE J, 1990, CLIN EXP IMMUNOL, V81, P123
[6]   Role of macrophage-colony-stimulating factor in regulating the accumulation and phenotype of tumor-associated macrophages [J].
Dougherty, ST ;
Eaves, CCJ ;
McBride, WH ;
Dougherty, GJ .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (03) :165-172
[7]   Tumor-induced immune dysfunction: The macrophage connection [J].
Elgert, KD ;
Alleva, DG ;
Mullins, DW .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (03) :275-290
[8]  
Fukumura D, 1997, AM J PATHOL, V151, P679
[9]   THE MONOCLONAL-ANTIBODY MAC387 DETECTS AN EPITOPE ON THE CALCIUM-BINDING PROTEIN MRP14 [J].
GOEBELER, M ;
ROTH, J ;
TEIGELKAMP, S ;
SORG, C .
JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 55 (02) :259-261
[10]  
Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO